BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9179272)

  • 1. Why is age such an important independent prognostic factor in acute lymphoblastic leukemia?
    Perentesis JP
    Leukemia; 1997 May; 11 Suppl 4():S4-7. PubMed ID: 9179272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lestingi TM; Hooberman AL
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):161-75. PubMed ID: 8449857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of karyotype with clinical features in childhood acute lymphoblastic leukemia].
    Shikano T
    Hokkaido Igaku Zasshi; 1989 Nov; 64(6):727-37. PubMed ID: 2606447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence peaks of the childhood acute leukemias reflect specific cytogenetic aberrations.
    Forestier E; Schmiegelow K;
    J Pediatr Hematol Oncol; 2006 Aug; 28(8):486-95. PubMed ID: 16912588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk childhood acute lymphoblastic leukemia in China: factors influencing the treatment and outcome.
    Luo XQ; Ke ZY; Huang LB; Guan XQ; Zhang YC; Zhang XL
    Pediatr Blood Cancer; 2009 Feb; 52(2):191-5. PubMed ID: 18989886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
    Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J
    Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in childhood acute lymphoblastic leukemia in Japan. Japan Association of Childhood Leukemia Study.
    Horibe K; Hara J; Yagi K; Tawa A; Komada Y; Oda M; Nishimura S; Ishikawa Y; Kudoh T; Ueda K
    Int J Hematol; 2000 Jul; 72(1):61-8. PubMed ID: 10979211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
    Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
    Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia.
    Ye J; Cao Q; Su X; Huang Q; Ma Z; Wang Z; Huang W; Chen Z; Chen S
    Chin Med J (Engl); 1997 Feb; 110(2):90-5. PubMed ID: 9594276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
    Ribera JM; Ortega JJ; Oriol A; Fontanillas M; Hernández-Rivas JM; Brunet S; García-Conde J; Maldonado J; Zuazu J; Gardella S; Besalduch J; León P; Macià J; Domingo-Albós A; Feliu E; San Miguel JF
    Haematologica; 1998 Mar; 83(3):222-30. PubMed ID: 9573676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and cytogenetic features in childhood acute lymphoblastic leukemia with 1; 19 translocation].
    Sikano T; Ishikawa Y; Konno M; Hatayama Y; Nakadate H; Hatae Y; Takeda T
    Rinsho Ketsueki; 1990 Jun; 31(6):793-8. PubMed ID: 2214170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy.
    Nachman JB; Sather HN; Sensel MG; Trigg ME; Cherlow JM; Lukens JN; Wolff L; Uckun FM; Gaynon PS
    N Engl J Med; 1998 Jun; 338(23):1663-71. PubMed ID: 9614257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The t(12:21) is underrepresented in childhood B-lineage acute lymphoblastic leukemia in Kerala, Southern India.
    Hill A; Short MA; Varghese C; Kusumakumary P; Kumari P; Morgan GJ
    Haematologica; 2005 Mar; 90(3):414-6. PubMed ID: 15749681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro drug resistance as independent prognostic factor in the study COALL-O5-92 Treatment of childhood acute lymphoblastic leukemia; two-tiered classification of treatments based on accepted risk criteria and drug sensitivity profiles in study COALL-06-97].
    Janka-Schaub GE; Harms DO; den Boer ML; Veerman AJ; Pieters R
    Klin Padiatr; 1999; 211(4):233-8. PubMed ID: 10472556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the childhood acute lymphoblastic leukemia with t(12;21)].
    Lin D; Liu SH; Zhu XF; Bo LJ; Li CW; Chen YM; Liu XP; Qin S; Dai Y; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):17-21. PubMed ID: 14990071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperdiploidy (greater than 50 chromosomes) has the most favorable prognosis among the major karyotypic subgroups of childhood acute lymphoblastic leukemia].
    Shikano T; Ishikawa Y; Kobayashi R; Konno M; Hatayama Y; Nakadate H; Hatae Y; Takeda T
    Rinsho Ketsueki; 1990 Mar; 31(3):308-14. PubMed ID: 2366333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.